BBVA USA Bancshares’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$10.2M Sell
62,094
-5,298
-8% -$857K 0.49% 49
2020
Q4
$10.6M Buy
67,392
+1,127
+2% +$166K 0.55% 37
2020
Q3
$9.72M Sell
66,265
-2,496
-4% -$369K 0.56% 40
2020
Q2
$9.67M Sell
68,761
-2,254
-3% -$328K 0.58% 36
2020
Q1
$9.31M Buy
71,015
+1,865
+3% +$265K 0.67% 31
2019
Q4
$10.1M Buy
69,150
+1,909
+3% +$259K 0.57% 39
2019
Q3
$8.7M Buy
67,241
+4,441
+7% +$585K 0.56% 43
2019
Q2
$8.75M Sell
62,800
-50
-0.1% -$6.92K 0.53% 42
2019
Q1
$8.79M Sell
62,850
-2,134
-3% -$286K 0.55% 41
2018
Q4
$8.39M Sell
64,984
-487
-0.7% -$67.9K 0.6% 40
2018
Q3
$9.05M Sell
65,471
-479
-0.7% -$63.7K 0.54% 41
2018
Q2
$8M Sell
65,950
-10,114
-13% -$1.26M 0.51% 45
2018
Q1
$9.75M Sell
76,064
-5,348
-7% -$723K 0.63% 37
2017
Q4
$11.4M Sell
81,412
-2,667
-3% -$371K 0.72% 29
2017
Q3
$10.9M Sell
84,079
-1,585
-2% -$210K 0.71% 30
2017
Q2
$11.3M Buy
85,664
+337
+0.4% +$43K 0.74% 30
2017
Q1
$10.6M Sell
85,327
-1,394
-2% -$167K 0.71% 33
2016
Q4
$9.99M Buy
86,721
+6,397
+8% +$739K 0.7% 34
2016
Q3
$9.49M Buy
80,324
+2,688
+3% +$326K 0.69% 34
2016
Q2
$9.42M Sell
77,636
-976
-1% -$111K 0.71% 32
2016
Q1
$8.51M Sell
78,612
-1,745
-2% -$181K 0.64% 34
2015
Q4
$8.25M Buy
80,357
+5,096
+7% +$512K 0.61% 40
2015
Q3
$7.03M Sell
75,261
-16,792
-18% -$1.62M 0.55% 45
2015
Q2
$8.97M Sell
92,053
-5,677
-6% -$569K 0.5% 56
2015
Q1
$9.83M Sell
97,730
-9,555
-9% -$972K 0.44% 68
2014
Q4
$11.2M Sell
107,285
-3,384
-3% -$357K 0.51% 57
2014
Q3
$11.8M Sell
110,669
-844
-0.8% -$87.5K 0.53% 52
2014
Q2
$11.7M Sell
111,513
-1,999
-2% -$202K 0.51% 55
2014
Q1
$11.2M Sell
113,512
-22,075
-16% -$2.05M 0.51% 58
2013
Q4
$12.4M Sell
135,587
-16,970
-11% -$1.56M 0.54% 47
2013
Q3
$13.2M Sell
152,557
-20,190
-12% -$1.81M 0.63% 40
2013
Q2
$14.8M Buy
+172,747
New +$14.7M 0.75% 33

Other funds holding JNJ

BBVA USA Bancshares's JNJ Position: Q1 2021 in Review

BBVA USA Bancshares reduced its Johnson & Johnson (JNJ) stake by 7.9% in Q1 2021, selling an estimated $857K and leaving 62,094 shares worth $10.2M. The position accounts for 0.49% of the portfolio, ranked #49.

BBVA USA Bancshares first reported a position in JNJ in Q2 2013 and has held it in 32 quarters since. The position peaked at $14.8M in Q2 2013. 3,317 funds tracked by Wall St. Rank hold JNJ as of Q1 2021.

  • BBVA USA Bancshares held 62,094 shares of Johnson & Johnson worth $10.2M as of Q1 2021.
  • BBVA USA Bancshares sold 5,298 Johnson & Johnson shares in Q1 2021, an estimated $857K.
  • Johnson & Johnson made up 0.49% of BBVA USA Bancshares's portfolio in Q1 2021, its #49 holding.
  • BBVA USA Bancshares first reported a position in Johnson & Johnson in Q2 2013 and has held it in 32 quarters since.
  • BBVA USA Bancshares's Johnson & Johnson position peaked at $14.8M in Q2 2013.
  • 3,317 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2021.

Based on BBVA USA Bancshares's 13F filing for Q1 2021, filed 23 Apr 2021.